Gene: CCDC25
Official Full Name: coiled-coil domain containing 25provided by HGNC
Gene Summary: Enables DNA binding activity. Involved in positive regulation of cell motility. Located in endomembrane system and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00417 | CCDC25 Knockout cell line (HCT 116) | Human | CCDC25 | 1:2~1:4 | Negative | Online Inquiry |
KO20837 | CCDC25 Knockout cell line (HeLa) | Human | CCDC25 | 1:3~1:6 | Negative | Online Inquiry |
KO20838 | CCDC25 Knockout cell line (HEK293) | Human | CCDC25 | 1:3~1:6 | Negative | Online Inquiry |
CCDC25 Gene Knockout Cell Lines are genetically engineered cellular models designed to study the specific function and biological relevance of the CCDC25 gene. Utilizing CRISPR-Cas9 technology, these cell lines have been meticulously crafted to disrupt the CCDC25 gene's expression, allowing researchers to investigate the resulting phenotypic changes and elucidate the pathways in which this gene is involved.
The primary function of CCDC25 is linked to cell cycle regulation and mechanistic processes facilitating cell division. By knocking out this gene, researchers can explore its role in various biological contexts, such as cancer development, stem cell differentiation, and cellular responses to stress. The resulting cell lines provide a valuable platform for studying the gene's contributions to these critical pathways and aid in the identification of potential therapeutic targets.
From a scientific standpoint, the CCDC25 Gene Knockout Cell Lines hold significant importance in both basic and translational research settings. Their application can lead to breakthroughs in understanding diseases where CCDC25 is implicated, such as certain cancers and genetic disorders. Furthermore, these cell lines serve as essential tools for drug discovery and developing gene therapies, thus bridging the gap between bench research and clinical applications.
One notable advantage of our CCDC25 Gene Knockout Cell Lines is their ease of use in a variety of experimental conditions, combined with the reliability of results they provide. Unlike traditional knockout methods, which can be cost-prohibitive and time-consuming, our optimized protocols ensure that researchers can obtain precise outcomes efficiently. Additionally, our cell lines are rigorously validated for consistency and reproducibility, offering an unparalleled resource compared to alternatives available on the market.
In conclusion, the CCDC25 Gene Knockout Cell Lines represent an invaluable asset for researchers and clinicians alike, providing a mechanistic understanding necessary for addressing complex biological questions. With our company’s commitment to advancing genetic research and our expertise in cellular model systems, we stand ready to support your investigations into the vital roles played by CCDC25 in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.